ScholarIQanswers from OpenAlex & ORCID
Torbjörn Fransson
ResearcherPublications, citations & collaboration network
Torbjörn Fransson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Torbjörn Fransson have?
ScholarIQindexed works
Torbjörn Fransson has 11 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Torbjörn Fransson have?
ScholarIQcitation count
Torbjörn Fransson has 344 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Torbjörn Fransson?
ScholarIQh-index
Torbjörn Fransson has an h-index of 6 in OpenAlex.
What is the i10-index of Torbjörn Fransson?
ScholarIQi10-index
Torbjörn Fransson has an i10-index of 6 in OpenAlex.
What is the ORCID of Torbjörn Fransson?
ScholarIQorcid
The ORCID for Torbjörn Fransson is on the source record.
What is the OpenAlex record for Torbjörn Fransson?
ScholarIQopenalex
The OpenAlex for Torbjörn Fransson is on the source record.
What are the most-cited papers on Torbjörn Fransson?
ScholarIQmost cited works
Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease
Joakim Nordanstig, Stefan James, Manne Andersson, Mattias Andersson, Peter Danielsson, Peter Gillgren, Martin Delle, Jan Engström, Torbjörn Fransson, Maher Hamoud, Anna Hilbertson, Patrik Johansson, Lars Karlsson, Björn Kragsterman, Hans Lindgren, Karin Ludwigs, Stefan Mellander, Niklas Nyman, Henrik Renlund, Birgitta Sigvant, Per Skoog, Joachim Starck, Gustaf Tegler, Asko Toivola, Maria Truedson, Carl‐Magnus Wahlgren, Jonas Wallinder, Andreas Öjersjö, Mårten Falkenberg
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial
Joakim Nordanstig, Stefan James, Manne Andersson, Mattias Andersson, Martin Delle, Jan Engström, Torbjörn Fransson, Peter Gillgren, Anna Hilbertson, Tal M. Hörer, Eva Jacobsson, Björn Kragsterman, Johan Lindbäck, Hans Lindgren, Karin Ludwigs, Stefan Mellander, Olle Nelzén, Robert Olin, Birgitta Sigvant, Per Skoog, Joachim Starck, Gustaf Tegler, Knut Thorbjørnsen, Maria Truedson, Carl‐Magnus Wahlgren, Jonas Wallinder, Andreas Öjersjö, Mårten Falkenberg
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial
Mårten Falkenberg, Stefan James, Manne Andersson, Mattias Andersson, Martin Delle, Jan Engström, Torbjörn Fransson, Peter Gillgren, Anna Hilbertson, Tal M. Hörer, Eva Jacobsson, Björn Kragsterman, Johan Lindbäck, Hans Lindgren, Karin Ludwigs, Stefan Mellander, Olle Nelzén, Robert Olin, Birgitta Sigvant, Per Skoog, Joachim Starck, Gustaf Tegler, Knut Thorbjørnsen, Maria Truedson, Carl‐Magnus Wahlgren, Jonas Wallinder, Andreas Öjersjö, Joakim Nordanstig
Primary Stenting of the Superficial Femoral Artery in Patients with Intermittent Claudication Has Durable Effects on Health-Related Quality of Life at 24 Months: Results of a Randomized Controlled Trial
Hans Lindgren, Peter Qvarfordt, Stefan Bergman, Anders Gottsäter, The Swedish Endovascular Claudication Stenting Trialists, Marianne Jansson, E. Litterfeldt, Hans Lindgren, Peter Qvarfordt, Torbjörn Fransson, Andreas Öjersjö, Anna Hilbertson, T. Röjlar, Anders Gottsäter, Gerald Gruber, Tal M. Hörer, Thomas Larzon, Torfi Jonasson, Charlotte Strandberg, Peter Andersson, Stefan Bergman, Lars Lundell, Anne-Marie Svensson, M. Warvsten
Drug-eluting balloon (DEB) versus plain old balloon angioplasty (POBA) in the treatment of failing dialysis access: A prospective randomized trial
Torbjörn Fransson, Anders Gottsäter, Mohammad Abdulrasak, Martin Malina, Timothy Resch